1. Home
  2. SHMD vs ARMP Comparison

SHMD vs ARMP Comparison

Compare SHMD & ARMP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SHMD
  • ARMP
  • Stock Information
  • Founded
  • SHMD 1864
  • ARMP N/A
  • Country
  • SHMD Germany
  • ARMP United States
  • Employees
  • SHMD N/A
  • ARMP N/A
  • Industry
  • SHMD
  • ARMP Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • SHMD
  • ARMP Health Care
  • Exchange
  • SHMD Nasdaq
  • ARMP Nasdaq
  • Market Cap
  • SHMD 86.1M
  • ARMP 80.0M
  • IPO Year
  • SHMD N/A
  • ARMP N/A
  • Fundamental
  • Price
  • SHMD $2.99
  • ARMP $1.95
  • Analyst Decision
  • SHMD
  • ARMP Strong Buy
  • Analyst Count
  • SHMD 0
  • ARMP 1
  • Target Price
  • SHMD N/A
  • ARMP $7.00
  • AVG Volume (30 Days)
  • SHMD 57.5K
  • ARMP 7.3K
  • Earning Date
  • SHMD 02-25-2025
  • ARMP 03-20-2025
  • Dividend Yield
  • SHMD N/A
  • ARMP N/A
  • EPS Growth
  • SHMD 1309.32
  • ARMP N/A
  • EPS
  • SHMD 1.07
  • ARMP N/A
  • Revenue
  • SHMD $99,752,404.00
  • ARMP $5,467,000.00
  • Revenue This Year
  • SHMD N/A
  • ARMP $23.87
  • Revenue Next Year
  • SHMD N/A
  • ARMP N/A
  • P/E Ratio
  • SHMD $2.41
  • ARMP N/A
  • Revenue Growth
  • SHMD N/A
  • ARMP 34.92
  • 52 Week Low
  • SHMD $1.86
  • ARMP $1.80
  • 52 Week High
  • SHMD $6.13
  • ARMP $4.48
  • Technical
  • Relative Strength Index (RSI)
  • SHMD N/A
  • ARMP 41.17
  • Support Level
  • SHMD N/A
  • ARMP $1.93
  • Resistance Level
  • SHMD N/A
  • ARMP $2.22
  • Average True Range (ATR)
  • SHMD 0.00
  • ARMP 0.11
  • MACD
  • SHMD 0.00
  • ARMP -0.01
  • Stochastic Oscillator
  • SHMD 0.00
  • ARMP 4.55

About SHMD SCHMID Group N.V. Class A Ordinary Shares

Schmid Group NV is a global supplier of equipment, software and services for various industries such as printed circuit board (PCB), substrate manufacturing, photovoltaics, and glass and energy storage with a focus on the highest end of this market in terms of technology and performance. It focuses on a modular product portfolio of machinery to use in the manufacturing of high-end PCB equipment and semiconductor packaging devices which includes common flexible circuit fabrication techniques such as subtractive, semi-additive processes (SAP) and modified semi-additive processes (mSAP).

About ARMP Armata Pharmaceuticals Inc.

Armata Pharmaceuticals Inc is a developer of pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat bacterial infections using its proprietary bacteriophage-based technology. The company is developing and advancing a broad pipeline of natural and synthetic phage candidates, including clinical candidates for Pseudomonas aeruginosa, Staphylococcus aureus, and other pathogens. In addition, in collaboration with Merck, the company is developing proprietary synthetic phage candidates to target an undisclosed infectious disease agent.

Share on Social Networks: